ONCOARENDI THERAP ZY-,01/ PLONCTH00011 /
2024-11-15 9:43:32 PM | Chg. -0.0900 | Volume | Bid9:50:11 PM | Ask9:50:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.1200EUR | -4.07% | - Turnover: - |
1.9120Bid Size: 1,194 | 2.2750Ask Size: 1,194 | 35.49 mill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -1.69 PLN | -33.98% |
EPS Diluted: | - PLN | -33.98% |
Revenues per Share: | 0.22 PLN | -59.49% |
Book Value per Share: | 5.99 PLN | 4.86% |
Cash Flow per Share: | -1.38 PLN | -43.13% |
Dividend per Share: | - PLN | - |
Total | Units_1_Short | |
Revenues: | 3,652,643.00 PLN | -51.39% |
Net Income: | -28,373,117.00 PLN | -21.08% |
Operating Cash Flow: | -23,290,040.00 PLN | - |
Cash and Cash Equivalents: | 63,988,140.00 PLN | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 41.94 | 89.88 |
P/BV ratio: | 1.52 | 3.25 |
P/CF Ratio: | -6.58 | -14.10 |
PEG: | 0.16 | - |
Earnings Yield: | -18.57% | -8.67% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 35.49 mill. EUR | 75.58 mill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 316,852.4678 EUR | 674,807.1734 EUR |
Shares Outstanding: | 16.84 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | -880.99% |
Net Profit Margin: | -776.78% |
Return on Equity: | -28.11% |
Return on Assets: | -25.27% |
Financial Strength
Liquidity I / Cash Ratio: | 1,058.97% |
Liquidity II / Quick Ratio: | 1,087.50% |
Liquidity III / Current Ratio: | 1,087.50% |
Debt / Equity Ratio: | 11.24% |
Dynam. Debt / Equity Ratio: | -48.71% |
Efficiency
Employees: | 112 |
Personal Expenses / Employee: | - PLN |
Revenues / Employee: | 32,612.88 PLN |
Net Income / Employee: | -253,331.40 PLN |
Total Assets / Employee: | 1,002,454.23 PLN |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | PLN |